tiprankstipranks
Trending News
More News >
Immuneering (IMRX)
NASDAQ:IMRX
US Market

Immuneering (IMRX) Stock Investors

Compare
346 Followers
Based on 800,570 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold IMRX
On average, investors allocate 0.00% of their portfolios to IMRX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 800,570 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding IMRX

0.9%
Last 7
Days
5.4%
Last 30
Days
Percentages indicate the change in the number of portfolios holding IMRX, out of 800,570 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

IMRX Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Reduced
2.47%
$2.47
Based on the activity of investors who made their portfolios public
The table shows changes in IMRX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

IMRX Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Viking Therapeutics
3.75%
-1.30%
-4.40%
3.11B
Healthcare
Marathon Digital Holdings
4.95%
-1.95%
-3.77%
5.51B
Financial
Intuitive Surgical
3.52%
-2.17%
-1.23%
194.50B
Healthcare
Riot Platforms
4.49%
-1.80%
-1.93%
3.19B
Financial
Recursion Pharmaceuticals
3.14%
-2.08%
-6.51%
1.68B
Healthcare
Spotify
4.97%
-1.06%
+3.03%
127.85B
Communication Services
DraftKings
4.36%
+0.21%
+2.46%
31.01B
Consumer Cyclical
Intuit
2.93%
+0.88%
-1.79%
186.21B
Technology
Applied Digital Corporation
4.20%
+1.42%
+1.36%
1.51B
Financial
Fortinet
3.40%
+0.36%
+1.30%
79.31B
Technology
Based on the activity of 800,570 active portfolios
Open your Smart Portfolio

IMRX Investor Analysis

IMRX investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
12.0%
of IMRX holders
are under 35
Average Segment Performance
Average P/E Ratio11.76
Beta4.25
Dividend Yield4.06%
IMRX investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
24.0%
of IMRX holders
are between 35–55
Average Segment Performance
Average P/E Ratio6.19
Beta11.21
Dividend Yield3.42%
IMRX investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
64.0%
of IMRX holders
are over 55
Average Segment Performance
Average P/E Ratio1.75
Beta6.30
Dividend Yield3.69%
Overview of age group and performance of IMRX stock investors
See who invests in IMRX according to age group and performance.

FAQ

How many retail Investors hold IMRX?
<0.1% of TipRanks' retail investors hold IMRX in their portfolios.
    What is IMRX Investor Sentiment?
    IMRX’s Investor Sentiment is Negative.
      What percentage of retail investors changed their holding of IMRX in the last 7 days?
      ▼ 0.9% of TipRanks' retail investors changed their holding of IMRX in the last 7 days.
        What percentage of retail investors changed their holding of IMRX in the last 30 days?
        ▼ 5.4% of TipRanks' retail investors changed their holding of IMRX in the last 30 days.
          What is the average age of retail investors who hold IMRX?
          The average age of IMRX Holders is over 55.
            What other stocks have IMRX investors also bought?
            IMRX Investors also bought VKTX, MARA, ISRG, RIOT, RXRX, SPOT, DKNG, INTU, APLD, FTNT.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis